359 related articles for article (PubMed ID: 29615628)
1. 'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.
Boer LM; Bischoff EW; Borgijink X; Vercoulen JH; Akkermans RP; Kerstjens HAM; Assendelft WJ; Schermer TR
NPJ Prim Care Respir Med; 2018 Apr; 28(1):12. PubMed ID: 29615628
[TBL] [Abstract][Full Text] [Related]
2. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
3. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
[TBL] [Abstract][Full Text] [Related]
4. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.
Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA
Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174
[TBL] [Abstract][Full Text] [Related]
5. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.
Mackay AJ; Donaldson GC; Patel AR; Jones PW; Hurst JR; Wedzicha JA
Am J Respir Crit Care Med; 2012 Jun; 185(11):1218-24. PubMed ID: 22281834
[TBL] [Abstract][Full Text] [Related]
7. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
[TBL] [Abstract][Full Text] [Related]
8. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
Tomioka R; Kawayama T; Suetomo M; Kinoshita T; Tokunaga Y; Imaoka H; Matsunaga K; Okamoto M; Hoshino T
Int J Chron Obstruct Pulmon Dis; 2016; 11():207-16. PubMed ID: 26893552
[TBL] [Abstract][Full Text] [Related]
9. The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations.
García-Sidro P; Naval E; Martinez Rivera C; Bonnin-Vilaplana M; Garcia-Rivero JL; Herrejón A; Malo de Molina R; Marcos PJ; Mayoralas-Alises S; Ros JA; Valle M; Esquinas C; Barrecheguren M; Miravitlles M
Respir Med; 2015 Dec; 109(12):1546-52. PubMed ID: 26542727
[TBL] [Abstract][Full Text] [Related]
10. COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study.
Kardos P; Vogelmeier CF; Worth H; Buhl R; Obermoser V; Criée CP
Lung; 2020 Jun; 198(3):507-514. PubMed ID: 32367415
[TBL] [Abstract][Full Text] [Related]
11. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
12. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
[TBL] [Abstract][Full Text] [Related]
13. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
14. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
[TBL] [Abstract][Full Text] [Related]
15. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.
Parulekar AD; Martinez C; Tsai CL; Locantore N; Atik M; Yohannes AM; Kao CC; Al-Azzawi H; Mohsin A; Wise RA; Foreman MG; Demeo DL; Regan EA; Make BJ; Boriek AM; Wiener LE; Hanania NA
J Am Med Dir Assoc; 2017 Dec; 18(12):1063-1068. PubMed ID: 29169736
[TBL] [Abstract][Full Text] [Related]
16. Time course and pattern of COPD exacerbation onset.
Aaron SD; Donaldson GC; Whitmore GA; Hurst JR; Ramsay T; Wedzicha JA
Thorax; 2012 Mar; 67(3):238-43. PubMed ID: 22008189
[TBL] [Abstract][Full Text] [Related]
17. The effect of pulmonary rehabilitation on COPD exacerbation frequency per year.
Sahin H; Varol Y; Naz I; Aksel N; Tuksavul F; Ozsoz A
Clin Respir J; 2018 Jan; 12(1):165-174. PubMed ID: 27240018
[TBL] [Abstract][Full Text] [Related]
18. Impact of symptom variability on clinical outcomes in COPD: analysis of a longitudinal cohort.
Kim MA; Suh MK; Park J; Kim JH; Kim TH; Kim EK; Oh YM; Lee SD; Lee JH
Int J Chron Obstruct Pulmon Dis; 2019; 14():2135-2144. PubMed ID: 31571850
[TBL] [Abstract][Full Text] [Related]
19. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
20. Predictors of exacerbations of asthma and COPD during one year in primary care.
Al-ani S; Spigt M; Hofset P; Melbye H
Fam Pract; 2013 Dec; 30(6):621-8. PubMed ID: 24115012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]